Using advanced microscopy to study brain tissue and improve treatment for brain diseases

Record Voxel Rate Nonlinear Optical Microscope to Unravel Brain Connectome and Signaling-Establish Reliably Electrophysiological Readouts From Human-induced Pluripotent Stem Cells (hiPSCs)-Derived Cerebral Organoids and Surgically Dissected Human Live Brains

NA · National Taiwan University Hospital · NCT05921786

This study is testing new ways to use brain tissue samples to improve treatments for brain diseases like tumors and help doctors plan better surgeries.

Quick facts

PhaseNA
Study typeInterventional
Enrollment500 (estimated)
Ages18 Years and up
SexAll
SponsorNational Taiwan University Hospital (other)
Drugs / interventionsradiation, chemotherapy, immunotherapy
Locations1 site (Taipei)
Trial IDNCT05921786 on ClinicalTrials.gov

What this trial studies

This research aims to create a comprehensive database of various brain tissues to validate the use of human brain tissue models and human-induced pluripotent stem cells (hiPSCs)-derived organoid models. It focuses on brain diseases, particularly brain tumors, where obtaining functional brain tissue samples is challenging. The study will utilize an electrophysiological system and a multiphoton microscope to gather detailed information about brain diseases before surgical interventions. This approach seeks to enhance the accuracy of surgical resection strategies and improve patient outcomes.

Who should consider this trial

Good fit: Ideal candidates are adults over 18 years old diagnosed with brain diseases who are suitable and willing to undergo resection surgery.

Not a fit: Patients who cannot provide consent, those with inconclusive tumor samples, or those undergoing biopsy surgery instead of resection will not benefit from this study.

Why it matters

Potential benefit: If successful, this study could lead to more precise surgical strategies and improved treatment outcomes for patients with brain diseases.

How similar studies have performed: Other studies have shown promise in using advanced imaging techniques for brain surgery, indicating potential success for this novel approach.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

1\. Patients older than the age of 18 with diagnosis of brain disease (both newly-diagnosed or recurrent) who are suitable and willing to receive resection surgery.

Exclusion Criteria:

1. Patients who cannot give consent to participate in the study.
2. The tumor samples failed to give a conclusive pathological diagnosis by standard pathological workflow.
3. Patients who only receives biopsy surgery rather than resection surgery.
4. Significant post-irradiation effect or radiation necrosis reported in the pathological examination.

Where this trial is running

Taipei

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Brain Diseases, Brain Tumor, brain diseases, brain tumor

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.